- Home
- BASE vs WGSWW Comparison
BASE vs WGSWW Comparison
Compare BASE & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BASE
- WGSWW
- Stock Information
- Founded
- BASE 2011
- WGSWW 2017
- Country
- BASE United States
- WGSWW United States
- Employees
- BASE N/A
- WGSWW N/A
- Industry
- BASE EDP Services
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- BASE Technology
- WGSWW Technology
- Exchange
- BASE Nasdaq
- WGSWW Nasdaq
- Market Cap
- BASE N/A
- WGSWW N/A
- IPO Year
- BASE 2021
- WGSWW N/A
- Fundamental
- Price
- BASE $17.90
- WGSWW $0.25
- Analyst Decision
- BASE Buy
- WGSWW
- Analyst Count
- BASE 14
- WGSWW 0
- Target Price
- BASE $23.00
- WGSWW N/A
- AVG Volume (30 Days)
- BASE 485.9K
- WGSWW 35.4K
- Earning Date
- BASE 02-25-2025
- WGSWW 02-18-2025
- Dividend Yield
- BASE N/A
- WGSWW N/A
- EPS Growth
- BASE N/A
- WGSWW N/A
- EPS
- BASE N/A
- WGSWW N/A
- Revenue
- BASE $204,633,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- BASE $17.74
- WGSWW N/A
- Revenue Next Year
- BASE $14.01
- WGSWW N/A
- P/E Ratio
- BASE N/A
- WGSWW N/A
- Revenue Growth
- BASE 19.27
- WGSWW 50.79
- 52 Week Low
- BASE $13.53
- WGSWW $0.21
- 52 Week High
- BASE $32.00
- WGSWW $0.25
- Technical
- Relative Strength Index (RSI)
- BASE 49.82
- WGSWW N/A
- Support Level
- BASE $18.20
- WGSWW N/A
- Resistance Level
- BASE $18.91
- WGSWW N/A
- Average True Range (ATR)
- BASE 0.61
- WGSWW 0.00
- MACD
- BASE -0.10
- WGSWW 0.00
- Stochastic Oscillator
- BASE 38.26
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.